Delivery Order SPE2DR25D2109-SPE2DR26F5ZSA
- Not listed
- The Defense Logistics Agency awarded a $28,435.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 21, 2026, for the supply of Zepbound 15 mg/0.5 ml pens. The order, with an ultimate completion date of January 22, 2026, will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order was awarded competitively with no set-aside designation and represents a single task order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,149.76 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 15, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The contract is a firm fixed-price delivery order with an ultimate completion date of January 16, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made on a non-set-aside, fully competitive basis, consistent with AmerisourceBergen's standard...
- The Defense Logistics Agency awarded a $8,745.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 5 mg/0.5 ml pens. The contract, which has no set-aside designation, is scheduled for completion by December 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on November 14, 2025, with a ceiling value of $6,631.49 and an ultimate completion date of November 17, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $14,024.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of January 13, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $22,256.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 16, 2026, for the supply of Zepbound 15 mg/0.5 mL pen injections, with an ultimate completion date of January 20, 2026. The contract carries no set-aside designation, indicating it was awarded through full and open competition. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on October 17, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with a ceiling value of approximately $14.8K. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 20, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $15,743.09 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on January 5, 2026, with completion scheduled for January 6, 2026. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply fulfillment under the company's broader pharmaceutical support framework. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the Defense...
- The Defense Logistics Agency awarded a $15,075.62 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. The order, which serves as a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA, is designated as a firm fixed-price delivery order with no set-aside provisions and is scheduled for completion by December 31, 2025. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $15,493.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 28, 2026, for the supply of Zepbound 5 mg/0.5 ml pens. The order is scheduled for completion by January 29, 2026, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's larger relationship with the...
- SPE2DR25D2109Indefinite Delivery Contract
- SPE2DR25D2109-SPE2DR26F5ZSADelivery Order
The Defense Logistics Agency awarded a $30,754.05 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pens, with a completion date of January 28, 2026. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. That primary contract vehicle provides comprehensive global pharmaceutical support for military healthcare programs, encompassing a broad range of medications, vaccines, medical supplies, and specialty pharmaceuticals. The supply of Zepbound, a diabetes medication, aligns with AmerisourceBergen's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains to support Defense Health Agency operations and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.8k | 1/26/26 |